These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14980769)

  • 21. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheological characterization of xanthan gum and hydroxypropylmethyl cellulose with respect to controlled-release drug delivery.
    Talukdar MM; Vinckier I; Moldenaers P; Kinget R
    J Pharm Sci; 1996 May; 85(5):537-40. PubMed ID: 8742947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets.
    Espinoza R; Hong E; Villafuerte L
    Int J Pharm; 2000 May; 201(2):165-73. PubMed ID: 10878323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of drug solubility on the release of slightly water-soluble drugs from HPMC matrices.
    Fu XC; Liang WQ; Wang GP
    Pharmazie; 2003 May; 58(5):355-6. PubMed ID: 12779057
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer.
    Ju RT; Nixon PR; Patel MV
    J Pharm Sci; 1995 Dec; 84(12):1455-63. PubMed ID: 8748329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of source variation on drug release from HPMC tablets: linear regression modeling for prediction of drug release.
    Piriyaprasarth S; Sriamornsak P
    Int J Pharm; 2011 Jun; 411(1-2):36-42. PubMed ID: 21420475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
    Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
    Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.
    Baluom M; Friedman M; Assaf P; Haj-Yehia AI; Rubinstein A
    Pharm Res; 2000 Sep; 17(9):1071-6. PubMed ID: 11087038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN; Schnaare RL; Sugita ET; Schwartz JB
    Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
    Lee BJ; Ryu SG; Cui JH
    Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of biphasic release tablets containing slightly soluble drugs.
    Maggi L; Machiste EO; Torre ML; Conte U
    Eur J Pharm Biopharm; 1999 Jul; 48(1):37-42. PubMed ID: 10477326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion coefficients of polymer chains in the diffusion layer adjacent to a swollen hydrophilic matrix.
    Ju RT; Nixon PR; Patel MV
    J Pharm Sci; 1997 Nov; 86(11):1293-8. PubMed ID: 9383743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L; Wang F
    Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.